Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kubra A, Coskun"'
Autor:
Kubra A, Coskun, Bercem Yeman, Kıyak, Kezban Ucar, Cifci, Elif, Kadioglu, Nazlican, Yurekli, Yusuf, Tutar
Publikováno v:
Current Pharmaceutical Biotechnology. 24:889-912
Abstract: Non-coding RNAs have a role in gene regulation and cellular metabolism control. Metabolism produces metabolites which are small molecules formed during the metabolic process. So far, a direct relationship between metabolites and genes is no
Autor:
Nazlıcan Yurekli, Elif Cansu Abay, Merve Tutar, Ecem Cabri, Kubra Acikalin Coskun, Alev Kural, Yusuf Tutar
Publikováno v:
Cancer Metastasis-Molecular Mechanism and Clinical Therapy
Cancer Metastasis-Molecular Mechanism and Clinical Therapy ISBN: 9781803561615
Cancer Metastasis-Molecular Mechanism and Clinical Therapy ISBN: 9781803561615
Breast cancer (BC) is one of the most frequently occurring diseases with high morbidity and mortality rates in the world today. BC cells live under stress with altered pathway signaling, chromosome and microsatellite instability, aneuploidy, hypoxia,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b89dfbe61b4e2cf477fb90ea1c144ddd
https://mts.intechopen.com/articles/show/title/molecular-mechanisms-of-breast-cancer-metastasis
https://mts.intechopen.com/articles/show/title/molecular-mechanisms-of-breast-cancer-metastasis
Autor:
Kubra Acikalin Coskun, Merve Tutar, Elif Cansu Abay, Nazlican Yurekli, Mervenur Al, Yusuf Tutar
Publikováno v:
Lymphoma
Cancer is the biggest health problem worldwide due to its high mortality rate. Lymphoma is defined as a group of malignant diseases that is caused by clonal proliferation of lymphocytes and is classified under two major groups: Hodgkin lymphoma and n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74cad433704aedc2d5a2b73693941241
https://mts.intechopen.com/articles/show/title/drugs-and-drug-candidates-for-the-treatment-of-lymphoma
https://mts.intechopen.com/articles/show/title/drugs-and-drug-candidates-for-the-treatment-of-lymphoma